Personal information

Activities

Employment (2)

UCL: London, GB

2009-09-01 to present | Professor of Viral Immunology (Infection and Immunity)
Employment
Source: Self-asserted source
Mala Maini

CNWL NHS Trust: London, Select a State or Province, GB

1998-09-01 to present | Honorary Consultant Physician
Employment
Source: Self-asserted source
Mala Maini

Education and qualifications (3)

Royal College of Physicians: London, London, GB

FRCP
Qualification
Source: Self-asserted source
Mala Maini

University of London: London, London, GB

1995-09-01 to 1998-08-31 | PhD
Qualification
Source: Self-asserted source
Mala Maini

University of London: London, London, GB

1981-09-01 to 1986-08-31 | MBBS
Qualification
Source: Self-asserted source
Mala Maini

Professional activities (10)

Association of Physicians: London, Select a State or Province, GB

Member
Service
Source: Self-asserted source
Mala Maini

Academy of Medical Sciences UK: London, GB

Fellow
Membership
Source: Self-asserted source
Mala Maini

Wellcome Trust: London, GB

2018-09-01 to present | Member of Clinical Fellowship Interview Panel
Service
Source: Self-asserted source
Mala Maini

Journal of Hepatology: Geneva, CH

2017-01-01 to present | Editorial Board
Service
Source: Self-asserted source
Mala Maini

Medical Research Club: London, Select a State or Province, GB

2006-01-01 to present | Elected member
Service
Source: Self-asserted source
Mala Maini

International Coalition to Eliminate HBV: Melbourne, AU

2021-01-01 to 2024-12-31 | Elected member of the Governing Board
Service
Source: Self-asserted source
Mala Maini

Academy of Medical Sciences: London, Select a State or Province, GB

2020-09-01 to 2023-08-31 | Member of Sectional Committee
Invited position
Source: Self-asserted source
Mala Maini

UK-Coronavirus immunology consortium: Birmingham, GB

2020-08-01 to 2021-07-31 | Theme Lead, Management Team
Service
Source: Self-asserted source
Mala Maini

International HBV Scientific Advisory Council: N/A, US

2017-01-01 to 2019-12-31 | Elected panel member
Membership
Source: Self-asserted source
Mala Maini

Wellcome Trust: London, London, GB

2014-09-01 to 2017-08-31 | Basic Science Interview Committee Member
Service
Source: Self-asserted source
Mala Maini

Funding (23)

(ICF)- IMMPROVE: Immune Memory and Mechanisms of Protection from Vaccines

2023-10-01 to 2028-09-30 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/Y004450/1
Source: Self-asserted source
Mala Maini via DimensionsWizard

Targeting the circadian clock to restore hepatitis B T-cell immunity

2023-09-01 to 2028-08-31 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/X020843/1
Source: Self-asserted source
Mala Maini via DimensionsWizard

ISOPLEXIS platform for single cell multiplexed functional proteomics of immune cells

2021-09-20 to 2024-09-19 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

223814/Z/21/Z

Source: Self-asserted source
Mala Maini via DimensionsWizard

A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium

2020-08-19 to 2021-08-18 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/V028448/1
Source: Self-asserted source
Mala Maini via DimensionsWizard

THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B

2020-01-01 to 2024-12-31 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 848223
Source: Self-asserted source
Mala Maini via DimensionsWizard

The impact of B cell phenotypes in HIV infection on antibody responses.

2019-09-22 to 2023-09-29 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: 2249900
Source: Self-asserted source
Mala Maini via DimensionsWizard

Harnessing tissue-resident CD8 T cells to manipulate hepatic immunity

2019-09-01 to 2024-08-31 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

214191/Z/18/Z

Source: Self-asserted source
Mala Maini via DimensionsWizard

The effects of short-term incubation of Gilead compounds on human intrahepatic and intestinal leucocytes

2019-08 to 2021-08 | Award
Gilead Sciences (CA, CA, US)
GRANT_NUMBER:

179496

Source: Self-asserted source
Mala Maini

HUNTER: Hepatocellular Carcinoma Expediter Network

2019-02 to 2024-01 | Grant
Cancer Research UK (London, GB)
Source: Self-asserted source
Mala Maini

Overcoming metabolic checkpoints for T cell immunotherapy of liver cancer

2018-10 to 2021-09 | Grant
Cancer Research UK (London, GB)
GRANT_NUMBER:

26603

Source: Self-asserted source
Mala Maini

UCL Wellcome Clinical Research Training Fellowship

2018-09 to 2021-12 | Award
Wellcome (London, UK, GB)
Source: Self-asserted source
Mala Maini

Bioinformatic delineation of the T cell receptor signature of hepatitis B virus control’

2018-08 to 2020-07 | Grant
Medical Research Foundation (London, GB)
Source: Self-asserted source
Mala Maini

Overcoming constraints on T cells in the HBV-infected liver

2017-03-01 to 2019-03-01 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

101849/Z/13/A

Source: Self-asserted source
Mala Maini via DimensionsWizard

Beyond checkpoint inhibitors: Natural killer cells limiting antitumor T cell immunity in hepatocellular carcinoma

2016-01-01 to 2018-12-31 | Grant
German Research Foundation (Bonn, DE)
GRANT_NUMBER: 323178777
Source: Self-asserted source
Mala Maini via DimensionsWizard

Natural Killer (NK) cell regulation of antiviral T cell responses in the pathogenesis of HIV infection

2015-07-31 to 2017-11-30 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/M008614/1
Source: Self-asserted source
Mala Maini via DimensionsWizard

Metabolic regulation of hepatic immunopathology by myeloid-derived suppressor cells

Harnessing the immune response in chronic HBV infection to optimise current treatment strategies.

2015-04-01 to 2017-12-30 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

107389/Z/15/Z

Source: Self-asserted source
Mala Maini via DimensionsWizard

The NKG2D pathway in hepatitis B associated hepatocellular carcinoma in a highly endemic setting

2014-04-02 to 2017-08-01 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

102772/Z/13/Z

Source: Self-asserted source
Mala Maini via DimensionsWizard

Redirecting T cells to overcome tolerance in chronic HBV infection

Source: Self-asserted source
Mala Maini via DimensionsWizard

Bim-mediated attrition of virus-specific CD8 T cells in chronic HBV infection

Source: Self-asserted source
Mala Maini via DimensionsWizard

Genomic analysis of the CD8 functional deficits associated with failure to control hepatitis B and hepatit

UCL Centre for Medical Molecular Virology

Source: Self-asserted source
Mala Maini via DimensionsWizard

Nucleos(t)ide withdrawal in HBeAg negative hepatitis B virus infection to promote HBsAg clearance(NUC-B)

Grant
National Institute for Health Research (London, GB)
Source: Self-asserted source
Mala Maini

Peer review (12 reviews for 4 publications/grants)

Review activity for Gut (3)
Review activity for Nature immunology. (6)
Review activity for Nature medicine. (2)
Review activity for Nature metabolism. (1)